Get your full text copy in PDF



Get your full text copy in PDF

Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells.

Anne Camirand, Yuhong Lu, Michael Pollak

Med Sci Monit 2002;8(12):BR521-526

ID: 4817


  • Personal copyFree
  • Educational copy199.00 USD
  • Commercial copy599.00 USD

Licence   [ read ]

I agree
Licence   [ read ]

I agree
Licence   [ read ]

I agree